Oric Pharmaceuticals, Inc. (ORIC)
13.17
-0.46
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
13.16
-0.01
(-0.08%)
After-Hours: 20:00
Oric Pharmaceuticals Market Cap : 1.365B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.365B |
| October 22, 2026 | 1.413B |
| October 21, 2026 | 1.435B |
| October 20, 2026 | 1.428B |
| October 19, 2026 | 1.318B |
| October 16, 2026 | 1.280B |
| October 15, 2026 | 1.323B |
| October 14, 2026 | 1.201B |
| October 13, 2026 | 1.172B |
| October 12, 2026 | 1.224B |
| October 09, 2026 | 1.243B |
| October 08, 2026 | 1.247B |
| October 07, 2026 | 1.245B |
| October 06, 2026 | 1.242B |
| October 05, 2026 | 1.294B |
| October 02, 2026 | 1.265B |
| October 01, 2026 | 1.298B |
| September 30, 2026 | 1.396B |
| September 29, 2026 | 1.386B |
| September 28, 2026 | 1.375B |
| September 25, 2026 | 1.364B |
| September 24, 2026 | 1.366B |
| September 23, 2026 | 1.381B |
| September 22, 2026 | 1.399B |
| September 21, 2026 | 1.313B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.326B |
| September 17, 2026 | 1.335B |
| September 16, 2026 | 1.300B |
| September 15, 2026 | 1.281B |
| September 14, 2026 | 1.311B |
| September 11, 2026 | 1.248B |
| September 10, 2026 | 1.251B |
| September 09, 2026 | 1.295B |
| September 08, 2026 | 1.308B |
| September 04, 2026 | 1.333B |
| September 03, 2026 | 1.320B |
| September 02, 2026 | 1.361B |
| September 01, 2026 | 1.336B |
| August 31, 2026 | 1.346B |
| August 28, 2026 | 1.372B |
| August 27, 2026 | 1.424B |
| August 26, 2026 | 1.442B |
| August 25, 2026 | 1.433B |
| August 24, 2026 | 1.395B |
| August 21, 2026 | 1.472B |
| August 20, 2026 | 1.438B |
| August 19, 2026 | 1.518B |
| August 18, 2026 | 1.443B |
| August 17, 2026 | 1.387B |
| August 14, 2026 | 1.437B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 3.58 |
| Price | 13.17 |
| Earnings Yield | -10.25% |